129 results
Page 4 of 7
8-K
EX-99.1
ec9 pyjgr85wkevld
14 May 20
Adaptimmune Reports Q1 Financial Results
7:37am
8-K
8zsr7x2tzuc5vyi9b
29 Apr 20
Other Events
8:06am
8-K
EX-99.1
jp890fkx60z9yq3ci03t
27 Feb 20
Adaptimmune Reports Fourth Quarter / Full Year 2019 Financial Results and Business Update
7:39am
8-K
EX-10.1
a2rqv4152u9mvs
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
424B5
tkr83avx79rxloph
22 Jan 20
Prospectus supplement for primary offering
5:31pm
424B5
bx7z0y456n7j3dolc64
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.1
k07eu5lw8d7oa zq
14 Jan 20
Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies
6:17am
8-K
EX-10.1
zdr8q jb952mbyx9ss
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-99.1
zkdqnluuuoes9
6 Nov 19
Adaptimmune Reports Third Quarter 2019 Financial Results and Business Update
7:35am
8-K
EX-10.1
l90 bkk5zg
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
8-K
EX-99.1
v6jscllh6m01o5k5gv40
1 Aug 19
Adaptimmune Reports Second Quarter 2019 Financial Results and Business Update
7:23am